By using a panel of melanoma cell lines harboring BRAF(V600E) mutation, the Authors showed that the BRAFi resistance leads to c-Jun and STAT3-mediated increase of PD-L1 expression [91]. The gene discussed is BRAF; the disease is melanoma.